Searched for
BIOTECH IPO NEWS
Flipkart puts IPO on ice; Rapido's $240 million raiseFlipkart has hit pause on its IPO in a jittery market. This and more in today's ETtech Top 5.- US market today: Biotech firm Odyssey hits nearly $900 million valuation as shares rise in Nasdaq debutOdyssey Therapeutics debuted on Nasdaq with an 11.1% surge, reaching a $899.9 million valuation. The autoimmune disease specialist successf...
- US Stocks | Kailera soars over 60% in Nasdaq debut as weight-loss drug race heats upKailera Therapeutics shares surged 62.5% in their Nasdaq debut after raising $625 million in a U.S. IPO priced at the top end of its range....
- US IPO hopefuls forge ahead with listing plans amid market swingsCompanies across sectors have resumed IPO roadshows despite Middle East tensions, signalling pent-up demand in the pipeline. Analysts expec...
- Vaccine maker Bharat Biotech said to mull $500 million IPOIndian vaccine developer Bharat Biotech International Ltd. is considering an initial public offering that may raise more than $500 million,...
- Concord Biotech to list on Friday. Here’s what GMP suggestsAnalysts are of the opinion that a market premium of over 15% on the issue price is justified based on the company's business model, which ...
- Concord Biotech IPO share allotment likely today. Here's how you can check statusOn the allotment date, investors get to know about the number of shares allotted to them as against the bids made. They can check the allot...
- Concord Biotech IPO: Issue subscribed 25 times on last day; check GMP and other detailsAnalysts advised investors to subscribe to the issue given its complex product portfolio, presence in niche space, strong client relationsh...
- SBFC Finance vs Concord Biotech: Which IPO should you pick?The issue of SBFC Finance comprises fresh equity issue of Rs 600 crore and an offer for sale (OFS) of Rs 425 crore, while Concord Biotech i...
- Concord Biotech IPO subscribed 58% on Day OneThe non-institutional investors (NII) category was subscribed the most at 1.01 times, followed by retail investors at 72%. The category for...
- Concord Biotech IPO opens. Should you subscribe to the issue?Analysts advised investors to subscribe to Concord Biotech IPO given its complex product portfolio, presence in niche space, strong client ...
- Concord Biotech IPO: GMP indicates strong investors' interest ahead of issue openingAhead of the issue opening, the company's shares commanded a premium of Rs Rs 325 in the unlisted market
- Concord Biotech IPO to open on August 4. Here are 10 things to know about the offerThe initial public offering (IPO) of Concord Biotech will open for subscription on August 4. The issue closes on August 8. The company's sh...
- Jhunjhunwala-backed Concord Biotech sets IPO price band at Rs 705-741According to the draft papers, Concord Biotech's IPO is entirely an offer for sale of (OFS) of 2,09,25,652 equity shares by Helix Investmen...
- Rare Enterprises, Quadria-backed Concord Biotech files draft IPO papers with SebiAs per an F&S report, Concord Biotech commands a market share of over 20 per cent by volume in 2021 across identified fermentation-based AP...
- Windlas Biotech IPO: Here's how to check allotment statusThe three-day IPO received bids for 13,77,39,750 shares against 61,36,252 shares on offer, as per NSE data.
- Windlas Biotech IPO subscribed 7 times on Day 2Windlas Biotech has already decided to allocate 26,18,706 equity shares at Rs 460 apiece to 22 funds aggregating to Rs 120.46 crore, accord...
- COVID-19 vaccine: Bhopal's GMC gets ready for Covaxin trialsBhopal, Nov 30 (IANS) The Gandhi Medical College (GMC) here is all set to conduct trials of coronavirus vaccine.
- Rossari Biotech plans to launch Rs 500-crore IPO next weekThis would be the first company to brave the current volatile markets.
- Rossari Biotech gets Sebi nod for IPOThe IPO comprises a fresh issue of Rs 150 crore and OFS of up to 1,05,00,000 equity shares.
Load More
